Medicine Information

"Winning the War Against Rheumatoid Arthritis"


RA is a condition that forces half of patients to become disabled from the work force within five to ten years? and reduces life expectancy by as much as 18 years. RA affects about one per cent of the world's adult population, most commonly women between the ages of 30 and 50.

The good news is that a tremendous amount of progress has been made within the last ten years in identifying patients earlier and treating the disease more aggressively. Patients with RA, if treated appropriately, can lead a relatively normal life. This is in stark contrast to the wheel-chair bound existence common as recently as 20 years ago!

Experts in the field consider early rheumatoid arthritis to be a medical emergency with mortality and morbidity equal to that for diabetes, asthma, heart disease, and other life-threatening conditions.

Rheumatoid arthritis attacks the joints in a symmetric fashion (both sides of the body affected equally) with the most common areas being the hands, wrists, ankles, knees, and feet. In addition to the swelling and pain, patients with RA often have profound fatigue and stiffness.

Rheumatoid arthritis is an autoimmune disease that attacks not only joints, but internal organs such as the blood vessels, lungs, heart, and eyes. Patients with RA are at increased risk for heart attack, stroke, and lymphoma.

Since many other types of arthritis such as gout, lupus, and osteoarthritis can look like RA a careful diagnostic approach is needed.

Laboratory testing has its pitfalls. The rheumatoid factor, a blood test found to be positive in about 80 per cent of individuals with RA, may also be positive in other disease conditions. Couple that with the fact that 20 per cent of patients with RA will be rheumatoid factor negative, then it becomes clear a diagnosis should not hinge on the results of blood tests alone.

Imaging procedures can also be misleading. Conventional x-rays often miss the erosions found with early disease. Newer imaging technologies such as magnetic resonance imaging (MRI) and ultrasound are much more sensitive.

After the diagnosis is made, there is even more hope for a patient today. In the past, non steroidal anti-inflammatory drugs (NSAIDS) used to be considered a cornerstone of therapy. That is no longer true.

Disease-modifying anti-rheumatic drugs (DMARDS) are being used earlier. Among the DMARDS currently being used are methotrexate, leflunomide (Arava), azathioprine (Imuran), sulfasalazine (Azulfidine), cyclosporine, and hydroxychloroquine (Plaquenil). These drugs attack the immune cells responsible for chronic inflammation. While DMARDS alone in combination are effective, they are relatively non-specific. Often, combinations of DMARDS are required.

Biologic Response Modifiers (BRMS) can target the disease more specifically than DMARDS. RA is a disease that is dependent on the signaling that occurs between immune cells. The signaling takes place through the use of special chemical messengers called cytokines. BRMS act at both the cytokine (chemical messenger) as well as the cellular level allowing the disease to be better controlled and in some instances put into remission.

Biologic response modifiers, which include drugs that suppress tumor necrosis factor (TNF), appear to be particularly effective.

Tumor necrosis factor is a protein that is produced by the immune cells. TNF is the major culprit responsible for inflammation-inducing damage. By block the effects of TNF, better control of RA can be achieved.

Three anti-TNF drugs are currently available: etanercept (Enbrel), adalimumab (Humira), and infliximab (Remicade). Another biologic drug, anakinra (Kineret) blocks interleukin, a different cytokine.

These drugs allow patients to have their disease controlled to such an extent that most are able to enjoy a normal work and leisure existence.

On the horizon are other biologic drugs that work at different points in the immune system- on different cytokines and on different pathways- to allow even greater as well as more specific control of disease. Since rheumatoid arthritis is a disease with many different cytokine and cellular mechanisms responsible for damage, attacking the disease at different points makes sense. In the future it may be possible to identify patients through specific tissue signals (called "biomarkers"). These biomarkers will allow physicians to type patients and give patients the specific therapy that will work best for them. Once that is achieved, the possibility of a cure becomes a reality.

Everything, though, starts with early accurate diagnosis. If damage is allowed to occur the chances for remission drop dramatically!

Dr. Wei (pronounced "way") is a board-certified rheumatologist and Clinical Director of the nationally respected Arthritis and Osteoporosis Center of Maryland. He is a Clinical Assistant Professor of Medicine at the University of Maryland School of Medicine and has served as a consultant to the Arthritis Branch of the National Institutes of Health. He is a Fellow of the American College of Rheumatology and the American College of Physicians. For more information on arthritis and related conditions, go to: http://www.arthritis-treatment-and-relief.com


MORE RESOURCES:
This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news


New York Times

Using Medicine and Science to Improve the Quality of Life
New York Times
To Ms. Onie, that story offers an example of what is wrong with America's health care system: It can be so focused on medicine that it misses the social issues that really drive health. For more than 20 years since she co-founded the nonprofit Health ...



Forbes

RoosterBio Is Targeting $67 Billion Global Regenerative Medicine Market
Forbes
When you hear about “Regenerative Medicine,” it is often about stem cell therapy and tissue engineering. These two innovations alone are driving the large industry market estimates ranging from four billion dollars to $67 billion. The National ...



Daily Record-News

New Ellensburg family practice doctor emphasizes functional medicine
Daily Record-News
“Functional medicine, a lot of it is working through nutrition, discovering and trying to pinpoint any underlying cause for the disease, rather than just treating it with medications,” Elperin said. “Functional medicine is a way to bring the body back ...



Business Insider

Trump gave Kim Jong Un a taste of his own medicine — and now North Korea is begging to save the summit
Business Insider
President Donald Trump on Thursday pulled a classic North Korean negotiating move by canceling his planned summit with Kim Jong Un. Within 12 hours of the cancellation, North Korea backtracked on threats to "reconsider" the summit. It now says it will ...

and more »


PhillyVoice.com

Why medicine leads the professions in suicide, and what we can do about it
PhillyVoice.com
Earlier this month, one of us visited a prominent U.S. medical school to give a lecture on the topic of burnout and how physicians can find more fulfillment in the practice of medicine. Sadly, that very day, a fourth-year medical student there took her ...



SCNow

Florence Family Medicine aims for personal touch
SCNow
FLORENCE, S.C. — Florence Family Medicine employees joined ambassadors from the Greater Florence Chamber of Commerce to hold a ribbon cutting Thursday morning. Florence Family Medicine, at 315 N. Beltline Drive, Suite E, provides primary care ...



Lifehacker Australia

Your Baby's Teething Medicine Could Be Dangerous
Lifehacker Australia
If you're a parent, you've been there. All the rocking, patting and rounds of “Old McDonald” in the world won't stop your baby's misery. After weeks of sleepless ...

and more »


Futurity: Research News

Don't give opioid cough medicine to kids. Here's why
Futurity: Research News
The findings support recent US Food and Drug Administration (FDA) restrictions on prescription hydrocodone- and codeine-containing cough medicines for children and suggests that opioids in general should not be prescribed for kids' coughs and colds.



The Guardian

Mambas, medicine and one girl's race to survive Kenya's biting problem
The Guardian
In a country where snakebite treatment is costly, hard to come by and often inadequate, Rashid Chiti feared the worst when his daughter was bitten by a black mamba. Now the World Health Assembly is about to pass a resolution that might finally boost ...



KETV Omaha

CHI, Nebraska Medicine team up to stop violence - KETV.com
KETV Omaha
Two local health systems are teaming up to prevent violence in the metro. CHI Health and Nebraska Medicine are working together with Omaha violence ...

and more »

Google News

home | site map | Dr. Thad Thomas
© 2006